These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 1625745)

  • 1. Allopurinol in the treatment of American cutaneous leishmaniasis.
    Herwaldt BL; Neva FA; Berman JD
    N Engl J Med; 1992 Aug; 327(7):498-9. PubMed ID: 1625745
    [No Abstract]   [Full Text] [Related]  

  • 2. Allopurinol in the treatment of American cutaneous leishmaniasis.
    Martinez S; Marr JJ
    N Engl J Med; 1992 Mar; 326(11):741-4. PubMed ID: 1738379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of cutaneous leishmaniasis recidivans with a combination of allopurinol and meglumine antimoniate: a clinical and histologic study.
    Esfandiarpour I; Dabiri SH
    Int J Dermatol; 2007 Aug; 46(8):848-52. PubMed ID: 17651170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of circulating lymphocyte subpopulations in canine leishmaniasis throughout treatment with antimonials and allopurinol.
    Miranda S; Martorell S; Costa M; Ferrer L; Ramis A
    Vet Parasitol; 2007 Mar; 144(3-4):251-60. PubMed ID: 17110042
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical follow-up examination after treatment of canine leishmaniasis.
    Moritz A; Steuber S; Greiner M
    Tokai J Exp Clin Med; 1998 Dec; 23(6):279-83. PubMed ID: 10622623
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful treatment of lupoid cutaneous leishmaniasis with glucantime and topical trichloroacetic acid (a case report).
    Nilforoushzadeh MA; Sadeghian G; Jaffary F; Ziaei H; Shirani-Bidabad L; Mahzoni P
    Korean J Parasitol; 2008 Sep; 46(3):175-7. PubMed ID: 18830058
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glucantime fever with parenteral meglumine antimonate in patients of cutaneous leishmaniasis.
    Rashid BN; Tabassum S; Ullah Rao MS; Masood S; Abbas MM; Mumtaz MJ
    J Coll Physicians Surg Pak; 2010 Jul; 20(7):496. PubMed ID: 20642959
    [No Abstract]   [Full Text] [Related]  

  • 8. Efficacy of cryotherapy versus intralesional meglumine antimoniate (glucantime) for treatment of cutaneous leishmaniasis in children.
    Layegh P; Pezeshkpoor F; Soruri AH; Naviafar P; Moghiman T
    Am J Trop Med Hyg; 2009 Feb; 80(2):172-5. PubMed ID: 19190206
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Glucantime and allopurinol in the treatment of persistent infantile visceral leishmaniasis].
    de la Cruz Amorós E; Lambruschini Ferri N; Rodríguez Miguélez JM; Torres Simón JM
    An Esp Pediatr; 1988 Jul; 29(1):77-9. PubMed ID: 3190011
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparing the efficiency of topical paromomycin with intralesional meglumine antimoniate for cutaneous leishmaniasis.
    Moosavi Z; Nakhli A; Rassaii S
    Int J Dermatol; 2005 Dec; 44(12):1064-5. PubMed ID: 16409282
    [No Abstract]   [Full Text] [Related]  

  • 11. Successful treatment of non-healing cases of cutaneous leishmaniasis, using a combination of meglumine antimoniate plus allopurinol.
    Momeni AZ; Aminjavaheri M
    Eur J Dermatol; 2003; 13(1):40-3. PubMed ID: 12609780
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of meglumine antimoniate in canine leishmaniasis.
    Lamothe J
    Vet Rec; 2004 Mar; 154(12):378. PubMed ID: 15074332
    [No Abstract]   [Full Text] [Related]  

  • 13. [N-methyl glucamine antimoniate or Glucantime].
    Rapp C; Simon F; Dordain ML
    Med Trop (Mars); 2000; 60(4):342-3. PubMed ID: 11436584
    [No Abstract]   [Full Text] [Related]  

  • 14. [Treatment of localized cutaneous leishmaniasis].
    Buffet P; Caumes E; Gentilini M
    Ann Dermatol Venereol; 1994; 121(6-7):503-11. PubMed ID: 7702288
    [No Abstract]   [Full Text] [Related]  

  • 15. Short report: efficacy of pentavalent antimony for treatment of colombian cutaneous leishmaniasis.
    Soto J; Toledo J; Vega J; Berman J
    Am J Trop Med Hyg; 2005 Apr; 72(4):421-2. PubMed ID: 15827279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PCR follow-up examination after treatment of canine leishmaniosis (CaL).
    Steuber S; Moritz A; Schirrmann I; Greiner M
    Tokai J Exp Clin Med; 1998 Dec; 23(6):285-92. PubMed ID: 10622624
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multicentric, controlled clinical study to evaluate effectiveness and safety of miltefosine and allopurinol for canine leishmaniosis.
    Miró G; Oliva G; Cruz I; Cañavate C; Mortarino M; Vischer C; Bianciardi P
    Vet Dermatol; 2009 Oct; 20(5-6):397-404. PubMed ID: 20178476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Psoriasiform cutaneous leishmaniasis.
    Veraldi S; Galloni C; Cremonesi R; Cavalli R
    Int J Dermatol; 2006 Feb; 45(2):129-30. PubMed ID: 16445503
    [No Abstract]   [Full Text] [Related]  

  • 19. A case of erysipeloid cutaneous leishmaniasis: atypical and unusual clinical variant.
    Ceyhan AM; Yildirim M; Basak PY; Akkaya VB; Erturan I
    Am J Trop Med Hyg; 2008 Mar; 78(3):406-8. PubMed ID: 18337335
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparative study between the efficacy of systemic meglumine antimoniate therapy with standard or low dose plus oral omeprazole in the treatment of cutaneous leishmaniasis.
    Nilforoushzadeh MA; Jaffary F; Ansari N; Siadat AH; Nilforoushan Z; Firouz A
    J Vector Borne Dis; 2008 Dec; 45(4):287-91. PubMed ID: 19248655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.